Life Sciences Advisory
Board-ready transformation advisory for high-stakes turnarounds, post-acquisition integrations, and commercial scale-up across regulated industries.
Embedded leadership model where execution risk is high, timelines are compressed, and enterprise value depends on right first-time outcomes.
Core Capabilities
From enterprise strategy to tactical execution, Landen translates strategic intent into operating models, investment priorities, and measurable value creation.
Operating model design, commercial and technical enablement, manufacturing strategy, and transformation leadership across regulated life sciences portfolios. Focused on growth, governance, and execution where regulatory complexity and capital exposure intersect.
Enterprise Quality System remediation, deployment, and modernization from crisis stabilization through inspection-readiness and sustained compliance across devices, combination products, diagnostics, and digital health assets.
External manufacturing and supply chain strategy across CMOs and external partners, including due diligence, partner qualification, governance model design, and portfolio optimization. Hands-on leadership for outsourced manufacturing, clinical supply chain, and post-acquisition integration.
Support for private equity and venture capital investors, including technical and regulatory diligence, integration planning, and identification and planning for value creation opportunities. Post-close execution certainty, not just pre-deal assessment.
Who We Serve
Boards, executive teams, and investors across regulated life sciences — particularly in development-stage and growth-phase companies where hands-on leadership and execution experience matters most.
Who Calls On Us
Service Providers
Mid-sized & large pharma service providers sharpening value propositions and growth models
Biotech
Early- and mid-stage biotech building partner strategies and scalable operations
Pharma / MedTech / Medical Device
Companies engaged in complex enterprise transformation, building sustainable compliance or integrating business units
Investors
Firms requiring operating partner diligence, integration planning, and execution governance
Track Record
Results across enterprise remediation, asset scale-up, post-acquisition integration, commercial launch, and cost / continuous improvement initiatives.
Initiatives are anchored in accountable leadership, budget discipline, and regulatory compliance.
Led diagnostic asset integration across quality and operations. Secured $220M in funding; onboarded operations, quality, and external supply chain resources. GMP manufacturing and lab restart in 6 months to first lot to stock.
Developed business development model generating ~$10M per year in large-scale manufacturing & lab equipment sales across Pharma and MedTech.
Led 160-person organization with a $40M budget supporting ~300 external partners & ~300 assets.
Led enterprise QMS remediation across 10 sites and 35 CMOs covering 60+ global processes for Top 5 Pharma.
Led asset under FDA EUA through manufacturing start-up; two ISO audits; enabled production of 1.5M units/quarter.
Built and scaled global quality/technical organizations (10x growth over 3 years); built device development and GMP testing labs.
How We Work
Reset operating models and deliver outcomes on compressed timelines with C-Suite and Board level accountability.
Corporate Strategic Planning for small to mid-size company growth planning and innovation for new products and services. In person strategy sessions available.
An embedded partner with accountability to deliver.
Diligence, integration, value creation plans, and execution governance for private equity and venture capital investors.
Personal advisory practice providing senior, hands-on execution leadership.
Engagements include Board-level reporting cadence, direct accountability for outcomes, and the ability to assemble a focused senior execution team as required.
Not a large consultancy — a deliberately small, senior practice built for high-stakes situations.
"Execution risk is high. Timelines are compressed. When enterprise value depends on right first-time transformation."
About
A board-ready life sciences executive and transformation leader with 25+ years of experience leading high-risk transformations, post-acquisition integrations, and commercial scale-ups across regulated environments.
He has held executive accountability for regulatory outcomes, capital deployment, and execution across complex portfolios spanning medical devices, combination products, pharmaceuticals, diagnostics, and digital health.
Nick translates strategy into practical operating models, investment priorities, and measurable value creation — operating comfortably within complex matrixed organizations or within a start-up environment.
Advice or Advice & Execution
We work alongside your teams to get things done right.
Cross-Functional Depth
Multiple Disciplines in a boutique practice to deliver strategy and execution.
Built for High Stakes
When execution risk is high and timelines are compressed, this is the practice built for that environment.
Get In Touch
Whether you're navigating a transformation, planning an integration, or facing a quality challenge — start with a conversation.